These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3482884)

  • 21. [Effect of the combined use of BCG, PPD, a protein-containing preparation from allogenic tissue and cyclophosphamide in the development of methylcholanthrene-induced tumors].
    Volegov AI
    Eksp Onkol; 1984; 6(2):63-5. PubMed ID: 6510338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sonodynamically-induced antitumor effect of mono-l-aspartyl chlorin e6 (NPe6).
    Yumita N; Iwase Y; Nishi K; Ikeda T; Komatsu H; Fukai T; Onodera K; Nishi H; Takeda K; Umemura S; Okudaira K; Momose Y
    Anticancer Res; 2011 Feb; 31(2):501-6. PubMed ID: 21378330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological analysis of chemotherapeutic effects for the effective immunochemotherapy against cancer].
    Yamada Y
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):721-7. PubMed ID: 6397415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
    Fisher B; Gebhardt M; Linta J; Saffer E
    Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters.
    Lemonde P
    Natl Cancer Inst Monogr; 1973 Dec; 39():21-32. PubMed ID: 4362522
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer.
    Soloway MS
    Natl Cancer Inst Monogr; 1978 Dec; (49):327-32. PubMed ID: 748788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New immunological approaches to the application of BCG vaccine for the treatments of tumors (acute leukoses).
    Ter-Grigorov VS; Yablokova TB; Levy DT; Rosenberg AM; Pisarenko NN; Levewbook IS; Graff IA
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):25-31. PubMed ID: 57195
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunotherapeutic studies on EN-L2C guinea pig leukemia].
    Miyamoto M
    Nihon Ika Daigaku Zasshi; 1986 Feb; 53(1):84-105. PubMed ID: 3456351
    [No Abstract]   [Full Text] [Related]  

  • 31. Phagocytosis of Mycobacterium bovis BCG organisms by murine S180 sarcoma cells.
    Devadoss PO; Klegerman ME; Groves MJ
    Cytobios; 1993; 74(296):49-58. PubMed ID: 8330487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
    Youn JK; Lacour F; Hue G
    Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):533-8. PubMed ID: 2487364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterial carrier and antitumour activity of the combination: BCG-cyclophosphamide.
    Hiu IJ
    Jpn J Exp Med; 1982 Dec; 52(6):287-90. PubMed ID: 7169673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pilot study on the effect of BCG vaccination in patients with bronchial carcinoma.
    Nilsson BS; Afeldt PE
    Scand J Respir Dis; 1975 Aug; 56(2):84-6. PubMed ID: 1172630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of ultrasound and hematoporphyrin on sarcoma 180.
    Yumita N; Nishigaki R; Umemura K; Umemura S
    Jpn J Cancer Res; 1990 Mar; 81(3):304-8. PubMed ID: 2112531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Short-term results of intratumor BCG injection for rectal carcinoma].
    Zhu HM
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):40-2. PubMed ID: 2364870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumors of the upper urothelium and cyclophosphamide: presentation of a case and review of the literature].
    de Castro Barbosa F; Rosell Costa D; Agüera Fernández L; Isa Kroon WA; Sánchez de la Muela P; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
    Arch Esp Urol; 1991 Dec; 44(10):1149-51. PubMed ID: 1817448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of the effect of radiotherapy, alkylating agents and phytohemagglutinin on sarcoma 180 in Swiss mice.
    Robinson E; Mekori T
    Eur J Cancer (1965); 1973 Feb; 9(2):125-31. PubMed ID: 4197897
    [No Abstract]   [Full Text] [Related]  

  • 40. [Polychemotherapy associated with oral BCG in the treatment of advanced breast carcinoma. Preliminary observations of a controlled therapeutic trial].
    da Silva Neto JB; Fontes CE; Varella D
    AMB Rev Assoc Med Bras; 1981 Jul; 27(7):198-9. PubMed ID: 7036244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.